GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alterity Therapeutics Ltd (FRA:PBN0) » Definitions » Cyclically Adjusted PB Ratio

Alterity Therapeutics (FRA:PBN0) Cyclically Adjusted PB Ratio : (As of Jun. 25, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Alterity Therapeutics Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Alterity Therapeutics Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Alterity Therapeutics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alterity Therapeutics Cyclically Adjusted PB Ratio Chart

Alterity Therapeutics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.37 0.39 0.60 0.31 0.17

Alterity Therapeutics Quarterly Data
Jun18 Dec18 Jun19 Sep19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.17 - - -

Competitive Comparison of Alterity Therapeutics's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Alterity Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alterity Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alterity Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Alterity Therapeutics's Cyclically Adjusted PB Ratio falls into.



Alterity Therapeutics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Alterity Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Alterity Therapeutics's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0/126.3989*126.3989
=0.000

Current CPI (Dec. 2023) = 126.3989.

Alterity Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
200806 17.947 85.071 26.666
200812 9.094 85.814 13.395
200906 6.361 86.278 9.319
200912 12.135 87.578 17.514
201006 9.365 88.971 13.305
201012 4.745 89.993 6.665
201106 11.129 92.129 15.269
201112 8.912 92.686 12.154
201206 9.015 93.244 12.221
201212 13.286 94.730 17.728
201306 15.727 95.473 20.821
201312 18.684 97.330 24.264
201406 31.889 98.352 40.983
201412 30.002 99.002 38.305
201506 30.220 99.838 38.260
201509 0.000 100.302 0.000
201512 27.094 100.673 34.017
201606 23.223 100.859 29.104
201612 21.575 102.159 26.694
201706 17.924 102.809 22.037
201712 14.604 104.110 17.731
201806 11.597 104.945 13.968
201812 7.691 105.967 9.174
201906 7.091 106.617 8.407
201909 0.000 107.174 0.000
201912 4.773 107.917 5.590
202006 2.535 106.246 3.016
202012 6.283 108.846 7.296
202103 0.000 109.496 0.000
202106 5.567 110.332 6.378
202109 0.000 111.168 0.000
202112 6.491 112.654 7.283
202203 0.000 115.069 0.000
202206 5.878 117.112 6.344
202209 0.000 119.248 0.000
202212 4.445 121.477 4.625
202303 0.000 123.148 0.000
202306 3.475 124.170 3.537
202309 0.000 125.656 0.000
202312 0.000 126.399 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Alterity Therapeutics  (FRA:PBN0) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Alterity Therapeutics Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Alterity Therapeutics's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Alterity Therapeutics (FRA:PBN0) Business Description

Traded in Other Exchanges
Address
350 Collins Street, Level 14, Melbourne, VIC, AUS, 3000
Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.

Alterity Therapeutics (FRA:PBN0) Headlines

No Headlines